EVERYTHING ABOUT HEMGENIX

Amount of eligible people: CDEC reviewed the uncertainty in the amount of people with moderately serious to intense hemophilia B in Canada eligible for etranacogene dezaparvovec. Medical experts consulted by CADTH indicated that some clients who will be categorized as acquiring mild or moderate ailment may have a significant bleeding phenotype, whi